PARLIAMENT QUESTION: HOMI BHABHA CANCER HOSPITALS AND RADIOPHARMACEUTICAL PRODUCTION CENTRES

1. At a Glance

• Homi Bhabha Cancer Hospitals (HBCH) are tertiary cancer-care facilities run by the Tata Memorial Centre (TMC), a Grant-in-Aid institution under the Department of Atomic Energy (DAE) [S1][S2].
• Radiopharmaceutical Production Centres are operated by BRIT (Board of Radiation and Isotope Technology), Mumbai, a constituent unit of DAE, supplying isotopes to 400+ nuclear medicine centres in India [S3].
• Demonstrates the dual-use civilian dividend of India's nuclear programme — bridging GS-III (Science & Tech) with GS-II (Health governance).

2. Why in the News

• PIB / Parliament Question (04 Feb 2026) by DAE giving hospital-wise data on commissioning year, beds, patients registered (2025) and surgeries performed (2025) for Tata Memorial Hospital, ACTREC, MPMMCC Varanasi and HBCHs [S1].
• PM inaugurated the 150-bed HBCH & Research Centre, Muzaffarpur (Bihar) on 22 August 2025 [S2].
• DAE Year End Review 2025 highlighted radiopharmaceutical and cancer-care expansion [S4].

3. Background & Evolution

• 1941 — Tata Memorial Hospital, Mumbai established (oldest cancer hospital in India) [S1].
• 1962 — Administrative control of TMH transferred to DAE [general DAE history].
• 2002 — ACTREC (Advanced Centre for Treatment, Research and Education in Cancer), Navi Mumbai commissioned [S1].
• 19 Feb 2019 — MPMMCC, Varanasi (Mahamana Pt. Madan Mohan Malaviya Cancer Centre) commissioned [S1].
• 2018 — Cabinet approved DAE/TMC takeover of Dr. B. Borooah Cancer Institute, Guwahati [S5].
• Aug 2022 — PM dedicated HBCH & Research Centre, Mohali (SAS Nagar) to the nation [S6].
• Aug 2025 — HBCH Muzaffarpur (Bihar) inaugurated [S2].

4. Core Static Facts

• Parent Ministry/Department: Department of Atomic Energy (under PMO, no Cabinet Minister) [S1].
• Implementing apex body: Tata Memorial Centre (TMC), Mumbai — a Grant-in-Aid institute of DAE [S2].
• Radiopharmaceutical producer: BRIT, Mumbai (constituent unit of DAE) [S3].
• HBCH network locations cited by PIB/DAE: Varanasi, Mullanpur (Mohali, Punjab), Sangrur, Visakhapatnam, Muzaffarpur [S2].
• Key isotopes produced via Dhruva reactor & medical cyclotron: Mo-99, I-125, I-131, Sm-153, Lu-177, F-18 [S3].
• Distribution reach: 400+ nuclear medicine centres nationwide [S3].
• Flagship indigenous teletherapy machine: Bhabhatron (BARC, transferred to industry) [S4].
• Hospital data (2025) from PIB Feb 2026 reply [S1]:
• Tata Memorial Hospital, Mumbai (1941) — 650 beds; 35,705 registered; 43,208 surgeries.
• ACTREC, Navi Mumbai (2002) — 500 beds; 8,970 registered; 12,588 surgeries.
• MPMMCC, Varanasi (19/02/2019) — 394 beds; 25,047 registered; 4,188 surgeries.
• HBCH Mullanpur (Punjab): 300-bed tertiary cancer hospital, built at ~₹660 crore [S6].
• HBCH Muzaffarpur (Bihar): 150-bed, commissioned 22 Aug 2025 [S2].
• Subsidy norm at TMC: ~60% patients (general category) receive free/highly subsidised care [S2].

5. Multi-Dimensional Analysis

Scientific / Technological - Reactor-based isotope production (Dhruva, Mumbai) + medical cyclotron for short-half-life PET isotopes (F-18) [S3]. - BARC-developed Bhabhatron indigenous radiotherapy unit reduces import dependence on Co-60 teletherapy machines [S4]. - Proton Therapy Facility at ACTREC, Kharghar — treated 500 patients within 2 years of inception [S7].

Social / Equity - Geographic decentralisation of cancer care into Tier-2/3 cities (Varanasi, Sangrur, Mohali, Muzaffarpur, Vizag) addresses catastrophic out-of-pocket health expenditure [S2]. - 60% subsidised slot for general-category patients — strong pro-poor cross-subsidy model [S2].

Administrative / Governance - Unusual placement: a tertiary health network under DAE, not MoHFW — rooted in radiation oncology expertise of BARC; coordinated with Ayushman Bharat for tertiary referrals [S4]. - TMC manages diverse acquired institutions (e.g., Dr. B. Borooah Cancer Institute, Guwahati) via Cabinet-approved takeovers [S5].

Strategic / Self-Reliance - Indigenous Lu-177 and Mo-99 production reduces reliance on global isotope supply (which faces chronic shortages) — aligns with Atmanirbhar Bharat in health-tech [S3].

6. Recent Developments (last 12-18 months)

• 04 Feb 2026 — DAE tables hospital-wise 2025 patient & surgery data in Parliament [S1].
• 22 Aug 2025 — HBCH & RC Muzaffarpur (150-bed) inaugurated by PM [S2].
• 2025 — DAE Year End Review flags continued expansion of cancer hospital and radiopharma network [S4].
• 2025 — Proton Therapy Facility at ACTREC crosses 500 patients milestone [S7].
• 2025 — Parliament Q on shortage of medical radioisotopes addressed by DAE [S3 family / PRID 2153081].

7. Prelims Hooks

• TMC, Mumbai is a Grant-in-Aid institute of Department of Atomic Energy (NOT Ministry of Health) [S2].
• Radiopharmaceuticals in India are produced by BRIT (Board of Radiation & Isotope Technology), Mumbai [S3].
• Bhabhatron = indigenous teletherapy machine developed by BARC [S4].
• Isotopes produced in Dhruva reactor (Trombay): Mo-99, I-125, I-131, Sm-153, Lu-177 [S3].
• F-18 is produced via medical cyclotron, not reactor [S3].
• ACTREC = Advanced Centre for Treatment, Research and Education in Cancer; Navi Mumbai; 2002 [S1].
• MPMMCC (full form: Mahamana Pandit Madan Mohan Malaviya Cancer Centre) — Varanasi, commissioned 19 Feb 2019 [S1].
• Dr. B. Borooah Cancer Institute, Guwahati was brought under TMC/DAE in 2018 [S5].
• HBCH locations: Varanasi, Mullanpur (Mohali), Sangrur, Visakhapatnam, Muzaffarpur [S2].
• HBCH Mullanpur: 300 beds, ~₹660 crore [S6].
• BRIT supplies to 400+ nuclear medicine centres in India [S3].
• DAE is under the Prime Minister's Office (no independent Cabinet Minister).

8. Mains Relevance

• GS-II: Issues relating to development & management of Social Sector — Health. Government policies for vulnerable sections.
• GS-III: Science & Technology — Indigenisation; Atomic Energy applications; Achievements of Indians in S&T.
• Plausible question stems: 1. "India's atomic energy programme has delivered significant civilian dividends beyond power generation." Discuss with reference to cancer care and radiopharmaceuticals. (GS-III, 250 words) 2. Examine the rationale and challenges of housing a tertiary cancer-care network under the Department of Atomic Energy rather than the Health Ministry. (GS-II) 3. Discuss how indigenous radioisotope and radiotherapy production strengthens India's health security and Atmanirbhar Bharat goals. (GS-III)

9. Related Topics to Study Next

• Atomic Energy Act, 1962 — statutory basis for DAE [legal underpinning].
• BARC, IGCAR, NPCIL, BRIT — DAE family of institutions.
• Ayushman Bharat — PM-JAY & Health Infrastructure Mission — complementary tertiary-care thrust.
• National Cancer Grid (NCG) — TMC-anchored network of 300+ cancer centres.
• Three-Stage Nuclear Programme — strategic context for DAE.
• Bhabhatron, AKRUTI, FOLPIK — DAE societal spinoffs.
• Lutetium-177 / PSMA therapy — global radiopharma trend.
• Cancer epidemiology in India (ICMR-NCRP) — burden data context.

10. Common Errors / Trap Areas

• HBCH/TMC come under DAE, NOT Ministry of Health & Family Welfare.
• BRIT ≠ AERB (the regulator). BRIT = isotope producer; AERB = Atomic Energy Regulatory Board.
• F-18 is cyclotron-produced; Mo-99/Lu-177 are reactor-produced — examiners swap these.
• MPMMCC is in Varanasi (UP) — not Mumbai; sometimes confused with TMH/ACTREC.
• Bhabhatron is a teletherapy machine, not a nuclear reactor or isotope.
• DAE has no Cabinet Minister — it is under the PMO; aspirants wrongly assign it to MoS S&T.

11. Sources

• [S1] PARLIAMENT QUESTION: HOMI BHABHA CANCER HOSPITALS AND RADIOPHARMACEUTICAL PRODUCTION CENTRES (PIB, DAE, 04 Feb 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2223303 — (tier: 1)
• [S2] PARLIAMENT QUESTION: CANCER TREATMENT CENTRES/HOSPITALS UNDER TATA MEMORIAL CENTRE AND DAE — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2238314 — (tier: 1)
• [S3] PARLIAMENT QUESTION: RADIOPHARMACEUTICAL PRODUCTS / Shortage of Medical Radioisotopes (PIB, DAE) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2238914 ; https://www.pib.gov.in/PressReleasePage.aspx?PRID=2153081 — (tier: 1)
• [S4] Department of Atomic Energy Year End Review 2025 — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2201302 — (tier: 1)
• [S5] Cabinet approves taking over of Dr. B. Borooah Cancer Institute, Guwahati by DAE/TMC — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1492233 — (tier: 1)
• [S6] PM dedicates Homi Bhabha Cancer Hospital & Research Centre, Mohali — https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1854147 — (tier: 1)
• [S7] TMC Proton Therapy Facility at ACTREC Kharghar treats 500 patients — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2156704 — (tier: 1)